4.7 Article

YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy

Seung-Woo Baek et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going?

Juan Carlos Pardo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

YAP Triggers Bladder Cancer Proliferation by Affecting the MAPK Pathway

Dandan Qiu et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Article Medicine, General & Internal

Identification of an immunotherapy-responsive molecular subtype of bladder cancer

Bic-Na Song et al.

EBIOMEDICINE (2019)

Review Oncology

YAP/TAZ Signaling and Resistance to Cancer Therapy

Chan D. K. Nguyen et al.

TRENDS IN CANCER (2019)

Review Oncology

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors

Chiara Casadei et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)

Review Biochemistry & Molecular Biology

The PDGF/PDGFR pathway as a drug target

Natalia Papadopoulos et al.

MOLECULAR ASPECTS OF MEDICINE (2018)

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Article Urology & Nephrology

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

Marko Babjuk et al.

EUROPEAN UROLOGY (2017)

Review Oncology

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Tsukasa Shibue et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Oncology

DNA Damage and Repair Biomarkers of Immunotherapy Response

Kent W. Mouw et al.

CANCER DISCOVERY (2017)

Article Biochemistry & Molecular Biology

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson et al.

Article Biochemistry & Molecular Biology

Alternative Wnt Signaling Activates YAP/TAZ

Hyun Woo Park et al.

Review Pharmacology & Pharmacy

Targeting the TGFβ pathway for cancer therapy

Cindy Neuzillet et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Article Biotechnology & Applied Microbiology

Bladder Carcinoma Data with Clinical Risk Factors and Molecular Markers: A Cluster Analysis

Enrique Redondo-Gonzalez et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Review Oncology

The Hippo pathway and human cancer

Kieran F. Harvey et al.

NATURE REVIEWS CANCER (2013)

Article Oncology

A Molecular Taxonomy for Urothelial Carcinoma

Gottfrid Sjodahl et al.

CLINICAL CANCER RESEARCH (2012)

Article Biochemical Research Methods

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

Matthew D. Wilkerson et al.

BIOINFORMATICS (2010)

Article Oncology

Bladder Cancer in 2010 How Far Have We Come?

Bruce L. Jacobs et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2010)